Today: 15 July 2026

Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

Why Celestica Stock Fell After Strong Earnings and a Bigger AI Forecast

Why Celestica Stock Fell After Strong Earnings and a Bigger AI Forecast

Celestica shares dropped after hours on Monday, despite the Canadian electronics firm posting better-than-expected quarterly profits and lifting its guidance for 2026—investors appeared to take profits in the AI infrastructure play. First-quarter revenue landed at $4.05 billion, a 53% jump from last year. Adjusted earnings per share hit $2.16, with that non-GAAP figure excluding certain costs.
27 April 2026
···
Critical Metals Corp Stock Rallies as $835 Million European Lithium Deal Targets Full Greenland Rare Earth Control

Critical Metals Corp Stock Rallies as $835 Million European Lithium Deal Targets Full Greenland Rare Earth Control

Critical Metals Corp. has struck a deal to acquire European Lithium Ltd. for roughly $835 million, looking to secure complete control over the Tanbreez rare earth project in Greenland. Tanbreez ranks among the world’s largest rare earth deposits; European Lithium currently holds the last 7.5% that Critical Metals doesn’t yet own.
27 April 2026
···
Intellia Therapeutics CRISPR Trial Win Puts One-Time HAE Drug On FDA Track

Intellia Therapeutics CRISPR Trial Win Puts One-Time HAE Drug On FDA Track

Intellia Therapeutics on Monday reported its experimental CRISPR gene-editing therapy led to a significant reduction in swelling attacks in a late-stage hereditary angioedema study. The company has started a rolling submission for U.S. approval of the drug, called lonvoguran ziclumeran, or lonvo-z. Designed as an outpatient infusion, lonvo-z targets a rare disorder that triggers severe swelling in areas like the face, airway, abdomen, and limbs.
27 April 2026
·
Snap Stock Jumps as Wall Street Sees a Profit Turn Coming

Snap Stock Jumps as Wall Street Sees a Profit Turn Coming

Snap Inc. shares jumped roughly 8.5% Monday, lifted by Rothschild & Co Redburn’s rating boost to Buy from Neutral. The firm also hiked its price target for the Snapchat owner all the way to $10, doubling the previous level. Lately, the stock traded at $6.13—well off its 52-week high, but making a strong move higher on the session.
27 April 2026
·
1 … 123 124 125 126 127 … 882

Stock Market Today

  • Stocks Tick Higher Before Bell as Iran Threat Lifts Oil
    July 15, 2026, 9:13 AM EDT. U.S. stock futures were mostly higher early Wednesday. Oil moved up after Iran threatened to block Middle East energy exports following U.S. sanctions. The warning put fresh supply risks back on the table, and markets reacted to the possibility of global oil disruption. Investors weighed the geopolitical risk as they watched both energy and equity markets ahead of the open.
Go toTop